Biomilennia is a biotechnology company focused on developing novel molecular diagnostic technologies. They specialize in using proprietary DNA-based assays for applications such as pathogen detection, microbial identification, and genetic testing. Biomilennia's technology aims to provide rapid, accurate, and cost-effective solutions for various industries including healthcare, food safety, environmental monitoring, and agriculture. Their innovative approaches to molecular diagnostics hold the potential to improve disease detection, streamline testing processes, and enhance overall safety and quality standards in various sectors.